India, Oct. 12 -- Bausch + Lomb Corporation (BLCO) is down 9.13 percent, losing $1.58 to $15.72 on Monday. The decline follows the announcement that Thomas J. Appio, CEO of parent company Bausch Health, has been appointed interim CEO of Bausch + Lomb, effective immediately. Brent Saunders, who had led the eye health company since 2023, will depart following a mutual agreement with the board. Bausch + Lomb is currently trading at $15.72, down from the previous close of $17.30 after opening at $16.83 on the New York Stock Exchange. The stock has traded between $15.48 and $16.83 during the session, with trading volume at 1.02 million shares versus average volume of 393,079. Appio joined Bausch + Lomb in 2010 and previously served as managing d...